Tony Cambridge/LinkedIn
May 17, 2026, 18:50
Tony Cambridge: Exploring the Pros and Cons of POCT D-Dimer in Diagnosing DVT
Tony Cambridge, Co-Chair Near Patient Testing Working Party at British In Vitro Diagnostics Association (BIVDA), shared a post on LinkedIn:
“New article alert – POCT Innovators explores the pros and cons of POCT D-dimer in diagnosing deep vein thrombosis.
One of our collaborators likened the use of POCT D-dimer to the ‘dark arts’, see why by reading our report!”
Stay updated with Hemostasis Today.
-
May 17, 2026, 18:47Krishna Kumar Dhakchinamoorthi: Artificial Intelligence in Deep Vein Thrombosis
-
May 17, 2026, 18:44Javed Anees: Megaloblastic Anemia – Biochemical Basis and Clinical Approach
-
May 17, 2026, 18:42Kishanlal Munshi: EC Approves Pfizer’s HYMPAVZI for Hemophilia A and B With Inhibitors
-
May 17, 2026, 18:15Shayan Mohammadmoradi: Interesting Global Study with Insightful Points on Women’s Awareness of VTE
-
May 17, 2026, 18:07Mae Galang: Apply for the Position of Rare Blood Disorder Account and Community Manager
-
May 17, 2026, 17:41Wolfgang Miesbach: What Does Acquired Haemophilia A Truly cost, Clinically and Economically?
-
May 17, 2026, 17:35Femi Ogunleye: New PhD Publication on Targeted Thrombolysis
-
May 17, 2026, 16:34Abdul Mannan: A Normal Factor Level Can Still Miss the Story
-
May 17, 2026, 16:12Double Your Impact Help Close the Hemophilia Diagnosis Gap and Expand Access to Life Saving Care – WFH